The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-06
DOI
10.1111/dom.14135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Atrial and brain natriuretic peptides: Hormones secreted from the heart
- (2018) Yasuaki Nakagawa et al. PEPTIDES
- Adrenomedullin as a Biomarker of Heart Failure
- (2018) Toshio Nishikimi et al. Heart Failure Clinics
- Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
- (2018) Signe Frøssing et al. Endocrine Connections
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Importance of Clinical Worsening of Heart Failure Treated in the Outpatient SettingCLINICAL PERSPECTIVE
- (2016) Naoki Okumura et al. CIRCULATION
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
- (2016) Anders Jorsal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
- (2016) Michael R. Zile et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natriuretic Peptides as Biomarkers in Heart Failure
- (2016) James L. Januzzi JOURNAL OF INVESTIGATIVE MEDICINE
- Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect
- (2015) João Pedro Ferreira et al. Clinical Research in Cardiology
- Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes
- (2014) Julie A. Lovshin et al. DIABETES CARE
- Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events
- (2014) Martin O'Donnell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)
- (2014) Anders Jorsal et al. BMJ Open
- MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI
- (2014) Søren Lindberg et al. European Journal of Preventive Cardiology
- Changes of Natriuretic Peptides Predict Hospital Admissions in Patients With Chronic Heart Failure
- (2014) Gianluigi Savarese et al. JACC-Heart Failure
- Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure
- (2011) Wayne L Miller et al. HEART
- Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis
- (2010) Michael Egstrup et al. EUROPEAN JOURNAL OF HEART FAILURE
- Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin
- (2009) John G.F. Cleland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)
- (2008) Serge Masson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More